http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110143995-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J63-008 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J63-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
| filingDate | 2019-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110143995-B |
| titleOfInvention | Azacyclo-substituted 18 beta-glycyrrhetinic acid derivative and preparation and application thereof |
| abstract | The invention belongs to the technical field of medicines, and particularly relates to an azacyclo-substituted 18 beta-glycyrrhetinic acid derivative, a preparation method and an application thereof, a pharmaceutical composition containing the azacyclo-substituted 18 beta-glycyrrhetinic acid derivative, an optical isomer thereof and a pharmaceutically acceptable salt thereof, and an application of the azacyclo-substituted 18 beta-glycyrrhetinic acid derivative, the optical isomer thereof and the pharmaceutically acceptable salt thereof in preparation of medicines for treating and/or preventing various cancers. The invention relates to a derivative shown in a general formula I, and an optical isomer and a pharmaceutically acceptable salt thereof, which have the following structures: wherein X, Y, Z, m are as described in the claims and specification. |
| priorityDate | 2019-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.